GeneCoda® Announces Formation of Advisory Board and Member Appointment

RTP, NC, August 22, 2018 — GeneCoda® announced today that it has formed an Advisory Board to assist in implementing the Company’s current plans and identifying future growth opportunities.  The Advisory Board will provide advice, recommendations, and guidance to the Board of Directors and Company management, related to corporate goals and strategy and other matters felt to be generally relevant to the development, growth, and profitability of the Company.

The initial appointments are Dr. Peter Johnson, MD, John Campbell, MS and Barry Buzogany, Esq.

Dr. Peter C. Johnson, MD is a University of Notre Dame and SUNY Upstate Medical University graduate. After General and Plastic Surgery training, Dr. Johnson practiced reconstructive surgery for ten years at U. Pittsburgh where he founded and was the first President of the Pittsburgh Tissue Engineering Initiative.  Subsequent roles were co-founder/CEO of Tissue Informatics, EVP of Life Sciences, CMO and CBO of Icoria, EVP, Entegrion, Inc. and VP, Research and Development and Medical and Scientific Affairs of Vancive Medical Technologies, an Avery Dennison business.  He presently serves as President and CEO of Scintellix, LLC and Co-Founding Principal of MedSurgPI, LLC, which provides novel, commercially-focused Medical Affairs services for pharmaceutical, biotechnology, medical device and related technology companies and institutions; to further the penetration of their technologies into clinical practice.

John Campbell is a Human Resources and Talent Management leader with over 25 years of experience in Fortune 500 organizations.  John has spent his career focused on enabling organizations to achieve greater HR sophistication and market leadership through “right” people practices…those that are simple and effective for the needs of a particular organization.  He has led HR, Talent Acquisition and Talent Development functions within such companies as Cree, Quintiles, American Express, LabCorp, and Pepsi.  As the Founder and Principal Consultant of Talent Outcomes LLC, a Human Resources and Talent consultancy, John now focuses his passion on helping small business owners to maximize their investment in their talent through smarter people practices that drive better business results.  John earned his MS in Industrial and Labor Relations, and a BS in Journalism, from West Virginia University.

Barry Buzogany, Esq is an accomplished corporate attorney and C-suite executive (CEO/COO/CLO) for the past 30+ years with both public and private life sciences and pharmaceutical companies, ranging in size from early stage to multinationals. He has held executive positions at Battelle Memorial Institute, Boehringer Ingelheim Pharma, Novo Nordisk, Centocor, and Gene Logic. Recent past companies include Icoria, Inc. (formerly Paradigm Genetics), then a publicly traded biotech in Research Triangle Park, NC where he served as Vice President & General Counsel before being named Chief Operating Officer; and President & CEO of Jenken Biosciences, Inc., an early stage drug development company.  He currently serves as a professional board director, business consultant and mentor to several healthcare-related technology companies. He has also served as a program speaker and panelist on the topic of the professional job search process.

“We are extraordinarily proud to have these leading experts with diverse experiences in drug development, operational leadership, corporate development, and business growth, on our advisory board,” said GeneCoda® President and Managing Director Don Alexander.  “With experience working directly for and serving dozens of companies in the Life Sciences industry, Peter, Barry, and John will use their respective talents to help us realize our potential as a leading executive and professional search firm focusing on the Life Sciences industry.